Weight Loss And ...

Can simply paying attention to your first bite of food change how much you eat? It sounds too simple to matter, but Holly and Jim are digging into a topic that might seem completely outside their lane: mindfulness and meditation.

For years, mindfulness has been filed under "stress management," not "weight management." But a growing body of research is asking a bigger question: can training the mind actually change the way we eat, not by altering our biology, but by changing how we respond to it? Holly and Jim break down a recent meta-analysis of dozens of studies to find out what's real, what's hype, and where this surprisingly powerful tool might fit into your own weight loss journey, especially the part everyone struggles with most: keeping the weight off.

Tune in as Holly and Jim separate the science from the sales pitch, tackle listener questions, and even reveal a personal update that might surprise you.

Discussed on the episode

• Why "eating on autopilot" happens to all of us and the moment Holly realized she was already halfway through a road trip sandwich she didn't remember eating
• The surprising reason automatic eating exists in the first place (hint: it's not laziness)
• What a 46-study meta-analysis reveals about mindfulness and eating behavior and why the effect is small but might matter more than you'd think
• Why this tool may matter far more for keeping weight off than for losing it in the first place
• The key difference between mindfulness and meditation (and why they get confused)
• A concept called "decentering" that could change the way you handle cravings
• Whether mindful eating is secretly just another diet in disguise
• One simple, five-minute-a-day habit almost anyone can start today.
• A rapid-fire round covering hunger vs. habit, biology vs. behavior, and myths about needing to "sit quietly with your eyes closed"
• A personal confession from Jim about a new daily practice he's been keeping quiet about

A few clicks online. No exam, no phone call, no video visit. Minutes later, a GLP-1 prescription is headed to your door. It sounds like the future of healthcare: fast, easy, convenient. But is convenience the same thing as care?

A Yale research team wanted to find out, so they built a fake patient, sent her to 49 different online GLP-1 providers, and tracked exactly what happened. What they found may change the way you think about getting these medications online and raise questions you didn't know to ask.

Join Holly and Jim as they unpack this eye-opening "secret shopper" study and use it to explore a much bigger question: when does convenience actually improve obesity care, and when does it quietly replace it? Whether you're currently taking a GLP-1, considering one, or just curious about where obesity treatment is headed, this episode will change how you evaluate any provider online or in person.

Discussed on the episode:

• The surprising percentage of online providers that approved a prescription in some cases in under five minutes
• The critical questions almost none of the 49 companies bothered to ask before prescribing a powerful medication
• Why "getting the meds" and "getting obesity care" are two very different things
• The real risks of starting a GLP-1 without a proper medical evaluation
• What compounded GLP-1s are, and why the vast majority of online prescriptions turned out to be compounded rather than brand-name
• Why your primary care doctor absolutely needs to know you're taking one of these medications (even if your online provider never asks)
• The dose-escalation practice that has Holly worried and why more medication isn't always better
• Holly and Jim's personal, unscripted stories about when convenience backfired in their own lives
• A simple framework for evaluating whether an online (or in-person) provider is actually giving you the care you deserve

For years, patients kept telling Holly the same strange thing: it wasn't the number on the scale that changed their life, it was something quieter, something they'd never had words for. They just didn't think about food anymore.

Now that experience has a name, and for the first time, a way to measure it. Food noise has gone from an offhand comment on social media to one of the most talked-about concepts in obesity science, and Holly and Jim are back to unpack how far the research has come since they last covered it.

Join Holly and Jim as they revisit food noise with fresh eyes. You'll hear how a handful of scattered patient stories turned into a full-blown scientific movement, what the newest validated tools can actually tell us, and why this "invisible" part of obesity might reshape how we think about treatment for years to come. Along the way, Holly and Jim get personal, sharing their own honest (and sometimes surprising) answers to whether they experience food noise themselves.

Discussed on the episode:

• How an unexpected side effect of GLP-1 medications turned into a full-blown scientific mystery
• The difference between food noise, hunger, and cravings, and why it matters more than you'd think
• Two newly validated tools researchers are using to measure something patients have described for years.
• A surprising decades-old study that raises the question: is food noise really new?
• A science-backed framework for understanding where food noise comes from in the brain
• Whether food noise could predict who regains weight, and who doesn't
• The big philosophical question: could reducing food noise become a treatment goal, even for people who don't need to lose weight?
• Holly and Jim's own personal, no-holds-barred answers to "do you have food noise?"
• What might happen to food noise if you stop taking a GLP-1 medication, and whether that means treatment "failed"

GLP-1 medications are the single most requested topic on the show, no contest. But with so much noise on social media, in doctors' offices, and everywhere in between, sorting fact from fiction has never been trickier. Some of what's out there is spot-on. Some of it is dangerously wrong.

So this week, Holly and Jim are flipping the format. Instead of another lecture, they're putting GLP-1 knowledge to the test with a 20-question quiz covering everything from the basic biology of these medications to the questions doctors themselves don't always get right. Grab a pen, keep score, and see how you stack up.

By the end of this episode, you'll have a clearer, science-backed answer to the questions you've been too afraid to ask or too confused by conflicting headlines to trust.

Discussed on the episode:

• The surprising truth about what GLP-1 medications are actually doing to your body (hint: it's not what most people think)
• Whether feeling less hungry is really a sign the medication is "working"
• Why a stalled scale might be the most normal thing that could happen to you
• The dosing myth that even well-meaning doctors sometimes get wrong
• What "success" really looks like when two people lose very different amounts of weight
• The truth behind "Ozempic face" and hair loss and whether the meds are really to blame
• Why almost everyone on a GLP-1 could benefit from one specific type of healthcare provider
• What to actually do (and not do) if you're eating less than 800 calories a day and still feel fine
• The real answer to "can I ever come off the medication?"
• Why those "natural GLP-1" gummies and supplements deserve a healthy dose of skepticism

We've all felt it: you decide to eat healthier, open social media, and within minutes, you're drowning in contradictory advice. Eggs are back. Butter's healthy. Seed oils are toxic. Never eat after 7pm. Wait, only eat between noon and 6pm? By the end, you're left wondering if anyone can just tell you what to eat.

Join Holly and Jim as they sit down with award-winning food journalist and registered dietitian Carolyn O'Neil to unpack why nutrition advice feels so exhausting and contradictory. With decades spent translating nutrition science for CNN and beyond, Carolyn has made a career out of turning "pie in the sky" science into "pie on the plate" advice people can actually use. In this conversation, she shares how to separate real science from clickbait, why food doesn't have to be the enemy, and how her philosophy of "the more you know, the more you can eat" can transform your relationship with food.

Whether you're confused by conflicting headlines, navigating a GLP-1 journey, or just trying to enjoy a family celebration without guilt, this episode is packed with practical, joyful wisdom from one of the most trusted voices in nutrition communication.

Discussed in the episode

• Why the two biggest buckets of nutrition headlines are "this will kill you" and "this will cure you," and why it's often the same food
• A simple media literacy trick for telling real science from a misleading headline
• What really happened in a viral study on omega-3 supplements and brain health
• Why the "Mediterranean diet" is more romanticized than most people realize
• How to keep the joy of eating alive while on a GLP-1 medication
• The restaurant industry's surprising response to guests eating less
• A simple framework, "the three M's," for personalizing your approach to health
• Why "shop the perimeter of the store" might be terrible advice.
• Carolyn's rapid-fire answers on the most overhyped nutrition claims, misleading headlines, and her favorite food city in the world
• A practical tip for enjoying food-centered family traditions without overeating or guilt

Cancer is the disease most people fear. But heart disease is the one that actually kills the most Americans, and most people never connect it to their weight. For decades, obesity was treated as a bystander to heart disease, a risk factor at best. That thinking has changed dramatically, and the data behind that shift is stunning: we now have a medication proven to cut major cardiovascular events by 20% in people with obesity.

Join Holly and Jim as they sit down with an old friend and true legend in the field, Dr. Robert Eckel, Professor Emeritus at the University of Colorado Anschutz Medical Campus. Bob is the only person to have ever served as president of the American Heart Association, the American Diabetes Association, and the Obesity Society, a hat trick that connects heart, metabolism, and weight in a way no one else in medicine can claim. He's been in the room for four decades of major turning points in this field, from the earliest meetings on obesity science to the current GLP-1 era.

In this episode, Bob walks Holly and Jim through the science, the skepticism, and the surprises behind the biggest shift in obesity treatment of their careers and answers real listener questions about medications, guidelines, and what patients should actually be asking their doctors.

Discussed in the episode:

• The pivotal trial that's changing how cardiologists think about weight loss drugs and how its results stack up against statins
• Why the outcome researchers expected to explain the benefits of these medications may not be the real story at all
• The surprising history of how "obesity" and "heart disease" became connected in medical thinking, and who had to make the case
• What your body's "set point" really is, and whether staying on medication long-term can actually change it
• A candid take on whether the weight-loss drugs might be helping or quietly working against long-term behavior change
• Real listener questions answered, including when a cardiologist won't prescribe, what "not overweight enough" really means, and whether weight loss "worked" even after a heart attack.
• Bob's own vulnerable reflections on his career, a decision he'd make differently, and what still keeps him "rewired" in retirement

For decades, one number has ruled the world of fitness: 10,000 steps. It's on your watch, your phone, maybe even tattooed into your daily to-do list. But what if that number was never based on science at all?

Join Holly and Jim as they sit down with Dr. Amanda Paluch, Associate Professor of Kinesiology at the University of Massachusetts Amherst and leader of the Steps for Health Collaborative, an international research consortium pooling data from over 125,000 adults to answer one deceptively simple question: how many steps do you actually need? Amanda pulls back the curtain on where the 10,000-step goal really came from, what the data shows instead, and why the "right" number might depend on how old you are. Whether you're chasing a step count, recovering from mobility limitations, or navigating GLP-1 medications, this conversation will change the way you think about your daily walk.

Discussed in the episode:

• The surprising 1960s marketing origin of the 10,000-step goal (hint: it has nothing to do with health research)
• Why the "right" step goal may look different depending on your age
• The step range where most of the cardiovascular benefit shows up (it's lower than you'd think)
• Whether walking pace matters as much as total volume
• How do steps fit into the GLP-1 conversation?
• What the research says about step counting becoming an unhealthy obsession
• Practical advice for people with mobility limitations who feel like step goals are out of reach
• Rapid-fire answers on walking vs. running, treadmill vs. outdoor steps, and more
• A simple mindset shift for anyone having a "low step day"

For 40 years, every time nutrition has found a new villain, the food industry has handed us a new label to go with it: non-fat, no GMOs, gluten-free, no seed oils, and now, non-ultra-processed. We have more experts, more studies, and more food rules than ever before, so why does standing in the grocery aisle still feel like such a guessing game?

Join Holly and Jim as they sit down with Tamar Haspel, the James Beard Award-winning Washington Post columnist behind Unearthed and author of To Boldly Grow, to pull apart the ultra-processed food debate and ask whether today's labels are actually helping us eat better or just making us easier to market to. Tamar doesn't just write about food from behind a desk: she gardens, fishes, raises chickens, and runs an oyster farm on Cape Cod, and she brings three decades of reporting, real skepticism, and zero patience for diet cranks to the conversation.

You'll hear why the food world keeps repeating the same mistake, what a cage full of B.F. Skinner's pigeons can teach us about our relationship with food, and what's really driving overeating once you strip away the marketing.

Discussed on the episode:

• The decades-old pattern that explains why every new food "villain" feels eerily familiar
• The bizarre pigeon experiment that reveals why we're so convinced certain foods are "good" or "bad" for us
• Why a bowl of crushed cereal proved more about overeating than years of processed-food headlines
• The blunt case for why "everything in moderation" might be the most useless diet advice out there
• The one-sentence grocery store rule that could replace almost every food label you've ever side-eyed
• How GLP-1 medications could end up reshaping the entire food industry, not just individual waistlines
• The "healthy" nutrient claim, Tamar says, is wildly overrated and the snack everyone blames for something it's not even guilty of

Losing weight on a GLP-1 medication can feel like magic until the scale stops moving. For almost everyone on these drugs, there comes a moment when the rapid progress slows, then stalls completely. Is the medication failing? Has your metabolism adapted? Did you do something wrong? For most people, that moment feels like a problem. It isn't.

Join Holly and Jim as they unpack one of the most misunderstood parts of the GLP-1 journey: the shift from losing weight to keeping it off. You'll discover why a stalled scale is actually a sign the medication is doing exactly what it's supposed to do, and why "maintenance" is a completely different physiological state than "weight loss." One that comes with its own rules. Along the way, you'll pick up science-backed (and some still-unanswered) guidance on nutrition, muscle, bone health, and motivation for the long haul, plus a clear answer to a question Holly says she gets all the time: Are they against staying on these medications long-term?

Discussed on the episode:

• Why hitting a plateau on a GLP-1 is good news, not a sign the drug has stopped working.
• The blood pressure pill comparison that reframes what people call "drug resistance"
• Why nutrition may matter even more, not less, once weight loss stops
• Whether you actually need to exercise to keep weight off on a GLP-1 (the honest answer might surprise you)
• The bone health risk in younger women that's getting far less attention than muscle loss
• Why are dose-tapering and switching strategies being called the "Wild West" of GLP-1 care
• A New York Times claim about these medications "rewiring the brain" and what that could mean long after you stop.
• How to find motivation once the scale refuses to budge

Have a question or a success story? Send it in. Holly and Jim read every one, and they're especially looking for listener stories about navigating weight loss maintenance.

What if the biggest obstacle to your health isn't your willpower, it's your zip code? Most of us have been raised to believe that weight and health come down to personal choices: what you eat, how much you move, how disciplined you are. But what if the deck has been stacked against millions of Americans before they ever make a single decision?

This week, Holly and Jim sit down with Dr. Christina Economos, Dean of the Friedman School of Nutrition Sciences and Policy at Tufts University, to explore one of the most important  and most overlooked dimensions of the obesity epidemic: the environments we live in. With decades of groundbreaking research behind her, including the landmark Shape Up Somerville study, Dr. Economos makes a compelling case that lasting health change can't happen one person at a time.

And with GLP-1 medications reshaping what's possible for individual weight loss, the conversation has never been more urgent. Does community still matter when we have powerful new treatments? Dr. Economos has a clear answer, and it just might change how you see your own role in the bigger picture.

Discussed on the episode:

• The landmark study that proved community-wide obesity prevention actually works in the real world, and the surprising ripple effect it had beyond the children involved.
• Why your zip code may predict your health outcomes nearly as powerfully as your genetics
• The hidden forces in your neighborhood that are quietly shaping what you eat and how much you move, often without you realizing it
• What a food environment assessment in the Mississippi Delta revealed perfectly captures the challenge millions of Americans face daily
• Why fixing schools alone won't fix childhood obesity, and what actually needs to happen instead
• The honest answer to how much of the obesity epidemic is biology versus environment (hint: it's not a clean split)
• The key ingredients, Dr. Economos says, every successful community health intervention must have, and the #1 mistake researchers keep making
• How GLP-1 medications and community health are more connected than you might think
• What "spark plugs" are, why every successful health movement has had them, and whether you could be one
• Real U.S. communities that are getting this right and what they're actually doing differently
• Practical steps anyone can take right now, even if your environment is working against you